Contents

Search


ertapenem (Invanz, Invance)

Tradename: Invanz Indications: - bacterial infections due to susceptible organisms - alternative to ceftriaxone or Zosyn for: - acute pelvic infections - complicated urinary tract infection (UTI) - intra-abdominal infections - abdominal abscess - bacterial peritonitis [2] - skin infections - diabetic foot infection - sepsis [2] - community-acquired pneumonia caused by: - penicillin-sensitive Streptococcus pneumonia - Haemophilus influenzae - beta-lactamase negative - prophylaxis for perioperative infection - gastrointestinal surgery [2] Dosage: IV QD dosing Dosage adjustment in renal failure: yes Antimicrobial activity: - Gram-positive bacteria: - Staphylococcus aureus (methicillin susceptible isolates only, MSSA) - Streptococcus agalactiae - Streptococcus pneumoniae (penicillin susceptible isolates only) - Streptococcus pyogenes - Gram-negative bacteria*: - Escherichia coli - Haemophilus influenzae (beta-lactamase negative isolates only) - Klebsiella pneumoniae - Moraxella catarrhalis - Proteus mirabilis - Anaerobic bacteria: - Bacteroides fragilis - Bacteroides distasonis - Bacteroides ovatus - Bacteroides thetaiotaomicron - Bacteroides uniformis - Clostridium clostridioforme - Eubacterium lentum - Peptostreptococcus species - Porphyromonas asaccharolytica - Prevotella bivia * does not cover Pseudomonas aeruginosa, use meropenem === in vitro data === - Gram-positive bacteria: - Staphylococcus epidermidis (methicillin susceptible isolates only) - Streptococcus pneumoniae (penicillin-intermediate isolates) - Gram-negative bacteria: - Citrobacter freundii - Citrobacter koseri - Enterobacter aerogenes - Enterobacter cloacae - Haemophilus influenzae (beta-lactamase positive isolates only) - Haemophilus parainfluenzae - Klebsiella oxytoca (excluding ESBL producing isolates) - Morganella morganii - Proteus vulgaris - Providencia rettgeri - Providencia stuartii - Serratia marcescens - Anaerobic bacteria: - Bacteroides vulgatus - Clostridium perfringens - Fusobacterium spp. Adverse effects: - seizures Note: Manufacturer Merck

Interactions

drug interactions

General

carbapenem (thienamycin)

Database Correlations

PUBCHEM correlations

References

  1. Prescriber's Letter 9(1):3 2002
  2. Deprecated Reference